PortfoliosStock ScreensStocksStockXcel

Interface Inc

TILE | US

30.50

USD

0.36

1.19%

TILE | US
Loading StockChartView...

About Interface Inc

Sector

Consumer Cyclical

Industry

Textile Manufacturing

Earnings date

30/06/2024

As of date

08/06/2026

Close

30.50

Open

30.23

High

31.05

Low

30.14

Interface Inc. designs produces and sells modular carpet products primarily in the United States and internationally. The company operates in two segments Americas (AMS) and Europe Africa Asia and Australia (EAAA). The company offers modular carpets under the Interface and FLOR brand names; luxury vinyl tiles and vinyl sheet under the Interface brand; carpet tiles under the CQuestGB name for use in commercial interiors include offices healthcare facilities airports educational and other institutions hospitality spaces and retail facilities as well as residential interiors; and modular resilient flooring products. It also provides carpet replacement installation and maintenance services; and rubber flooring under the norament and noraplan brand names. The company produces and sells an adapted version of its carpet tile for the healthcare facilities market. In addition it sells a proprietary antimicrobial chemical compound under the Intersept name; sells TacTiles a carpet tile installation system as well as various adhesives and products; and provides turnkey project management services for global accounts and other customers through its InterfaceSERVICES business. The company sells its products directly to end-users as well as indirectly through independent contractors installers or distributors. Interface Inc. was incorporated in 1973 and is headquartered in Atlanta Georgia.

View Less

TILE | US

Risk
35.6
Sharpe
1.27
Luna's Score
58/100
Recommendation
Hold

Luna says (TILE | US)

What's Working

Positive Momentum

Strength based on increasing price with high volume

Value Stock (Price to Book < 3)

Strong Sharpe Ratio (> 1.2)

What's not Working

Smallcap (300M - 2B USD)

High Market Beta (> 0.8)

High Debt to Equity (> 0.75)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

Loading RiskMeterView...

10 days

21.6%

1 month

35.6%

3 months

37.7%

6 months

32.6%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

17.81

Fwd. PE

14.53

Price to book

2.60

Debt to equity

1.06

Debt to assets

0.39

Ent. to EBITDA

9.33

Ent. to rev.

1.22

PEG

0.97

Other Fundamentals

EBITDA

171.17M

MarketCap

1.78B

MarketCap(USD)

1.78B

Div. yield

0.20

Op. margin

10.72

Erngs. growth

41.40

Rev. growth

5.20

Ret. on equity

15.83

Short ratio

1.28

Short perc.

1.90

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bullish (SMA1M > SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

2.88

Range1M

4.01

Range3M

6.65

Volumes: Market Activity

Volume Averages

Loading VolumeAverageView...

Rel. volume

1.11

Price X volume

19.71M

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
No data

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Clover Leaf Financial CorpCLOVHealthcare Plans3.921.95B2.35%n/a1.23%
Bausch Health Companies IncBHCDrug Manufacturers-Specialty & Generic5.111.88B-4.84%n/a-1843.40%
Perrigo Company plcPRGODrug Manufacturers-Specialty & Generic11.611.58B7.20%n/a93.52%
Phibro Animal Health CorporationPAHCDrug Manufacturers-Specialty & Generic31.761.29B-2.07%401.17204.74%
Alvotech Ordinary SharesALVODrug Manufacturers-Specialty & Generic4.241.28B19.77%n/a-196.14%
Harrow Health IncHROWDrug Manufacturers-Specialty & Generic33.11.17B-0.27%n/a331.16%
Collegium Pharmaceutical IncCOLLDrug Manufacturers-Specialty & Generic33.271.07B-0.33%14.45258.31%
Karyopharm Therapeutics IncKPTIDrug Manufacturers-Specialty & Generic8.51.06B-6.39%n/a-148.05%
Pacira Pharmaceuticals IncPCRXDrug Manufacturers-Specialty & Generic22.861.05B0.48%13.0573.76%
OPKO Health IncOPKDrug Manufacturers-Specialty & Generic1.43989.54M-0.69%n/a19.31%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA9.33--
Ent. to Revenue1.22--
PE Ratio17.81--
Price to Book2.60--
Dividend Yield0.20--
Std. Deviation (3M)37.68--
Debt to Equity1.06--
Debt to Assets0.39--
Market Cap1.78B--
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007